Currently out of the existing stock ratings of Tessa Romero, 59 are a BUY (70.24%), 21 are a HOLD (25%), 4 are a SELL (4.76%).

Tessa Romero

Work Performance Price Targets & Ratings Chart

Analyst Tessa Romero, currently employed at JPMORGAN, carries an average stock price target met ratio of 42.62% that have a potential upside of 27.89% achieved within 99 days.

Tessa Romero’s has documented 162 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 28-Sep-2025.

Wall Street Analyst Tessa Romero

Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 10/3/2024. The price target of $18 was fulfilled within 4 days with a profit of $10.93 (154.6%) receiving and performance score of 386.49.

Average potential price target upside

of $36.12 (42.94%) on CYTK (CYTOKINETICS).
of $14.06 (127.62%) on EWTX (EDGEWISE THERAPEUTICS).
of $8.3 (99.35%) on SRRK (SCHOLAR ROCK HOLDING CORP).

EWTX Edgewise Therapeutics GBT Global Blood Therapeutics ORTX Orchard Therapeutics PLC ATRA Atara Biotherapeutics RIGL Rigel Pharmaceuticals SRRK Scholar Rock Holding Corp YMAB Y mAbs Therapeutics CYTK Cytokinetics XENE Xenon Pharmaceuticals ACAD ACADIA Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd AGIO Agios Pharm DYN Dyne Therapeutics EYPT Eyepoint Pharmaceuticals MCRB Seres Therapeutics NMRA Neumora Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tessa Romero (JPMORGAN)